Skip to main content
Article
Effects of once-weekly dulaglutide on kidney function in patients with type 2 diabetes in phase II and III clinical trials.
Diabetes, Obesity and Metabolism (2017)
  • Katherine R. Tuttle, University of Washington
  • T. Dwight McKinney, Eli Lilly and Company
  • Jaime A. Davidson, University of Texas Southwestern Medical Center
  • Greg Anglin, Eli Lilly and Company
  • Kristine D. Harper, Eli Lilly and Company
  • Fady T. Botros, Eli Lilly and Company
Publication Date
January 3, 2017
DOI
10.1111/dom.12816
Citation Information
Katherine R. Tuttle, T. Dwight McKinney, Jaime A. Davidson, Greg Anglin, et al.. "Effects of once-weekly dulaglutide on kidney function in patients with type 2 diabetes in phase II and III clinical trials." Diabetes, Obesity and Metabolism Vol. 19 Iss. 3 (2017) p. 436 - 441
Available at: http://works.bepress.com/katherine-tuttle/18/